Keith Crandell, Director at Twist Bioscience Corp (TWST), sold 816,834 shares at $106.93 ($9.6M) on 2021-08-12, disclosed to the SEC on 2021-08-13.
Open-market sale of $9.6M TWST by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 286,480 | $0 | 0.0% |
| 2 | $0.00 | 214,828 | $0 | 0.0% |
| 3 | $0.00 | 225,526 | $0 | 0.0% |
| 4 | $106.93 | 1,412 | $151K | 1.6% |
| 5 | $106.93 | 1,412 | $151K | 1.6% |
| 6 | $106.98 | 41,033 |
| $4.4M |
| 45.6% |
| 7 | $106.98 | 41,033 | $4.4M | 45.6% |
| 8 | $107.56 | 2,555 | $275K | 2.9% |
| 9 | $107.56 | 2,555 | $275K | 2.9% |
| Total | $11.79 avg | 816,834 | $9.6M | 100% |
| Filing → |
| MASS | BUY | 2020-12-22 | $6.0M | — | Filing → |
| TWST | SELL | 2020-12-09 | $15.5M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |